Skip to main content
. Author manuscript; available in PMC: 2008 Jan 1.
Published in final edited form as: Nucl Med Biol. 2006 Nov 28;34(1):109–116. doi: 10.1016/j.nucmedbio.2006.10.005

Table 2.

Biodistribution of 7’ (Z)-[125I]iodorotenone (9) in Sprague-Dawley male rats

Tissue 1 h (n=7) 2 h (n=6) 24 h (n=4)
blood 0.130 ± 0.020 0.135 ± 0.019 0.063 ± 0.010
heart 3.707 ± 0.203 2.959 ± 0.244 0.607 ± 0.109
lung 0.352 ± 0.055 0.326 ± 0.050 0.102 ± 0.017
liver 1.557 ± 0.201 1.169 ± 0.188 0.267 ± 0.052
kidney 1.257 ± 0.118 0.933 ± 0.092 0.212 ± 0.037
spleen 0.275 ± 0.036 0.229 ± 0.013 0.062 ± 0.012
muscle 0.507 ± 0.077 0.536 ± 0.074 0.199 ± 0.050
fat 0.723 ± 0.193 1.018 ± 0.284 1.034 ± 0.144
brain 0.436 ± 0.038 0.341 ± 0.035 0.040 ± 0.004
thyroida 0.154 ± 0.057 0.339 ± 0.096 3.784 ± 0.647
heart:blood 28.94 ± 3.61 22.35 ± 3.83 9.737 ± 2.239
heart:lung 10.68 ± 1.34 9.316 ± 1.978 6.118 ± 1.716
heart:liver 2.402 ± 0.209 2.570 ± 0.334 2.284 ± 0.310

Male Sprague-Dawley rats (∼200 grams) were injected iv with 15-20 μCi of Z-[125I]iodorotenone in 10% ethanol saline.

Tissue distribution values are given as percent injected dose / gram and presented as mean ± standard deviation.

a

Thyroid values are given as percent injected dose/ organ.